Article: Gene therapy industry should see brighter days.(Bruce A. Hironaka of Cell Genesys Inc. speaks at Gene Therapy and Genomics meeting (San Diego,California))(Industry Overview)

Today's gene therapy business looks "bleak," admits Bruce A. Hironaka, but the future looks much brighter.

Hironaka, vice president of corporate development at Cell Genesys, Inc. presented his outlook on growth opportunities at last week's third annual Gene Therapy and Genomics meeting at the Westin Horton Plaza in San Diego.

"There will be a significant demand for gene therapy," Hironaka said in a cheery introductory greeting. But he didn't hesitate to admit "it's a tough market."

While experimental gene therapy, which involves inserting or replacing a functioning gene into the DNA of a patient to replace a missing or defective one, remains a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!